The Obesity Treatments (Wegovy) theme has 13 member stock(s) today, with an average return of -1.3%. The leading stock is 한미약품 (+2.2%, trading value 62,382,170,750).
A theme around GLP-1 class novel drugs demonstrating powerful weight-loss effects, drawing attention as the hottest cash cow in the pharmaceutical/bio market while causing global shortages.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 한미약품 | 474,000 | +2.2% | 62,382,170,750 |
| 큐라티스 | 2,950 | +2.1% | 83,542,000 |
| HLB펩 | 4,215 | 0.0% | 3,111,445 |
| 셀트리온제약 | 39,400 | 0.0% | 2,115,186,000 |
| DXVX | 2,380 | 0.0% | 165,931,645 |
| 유한양행 | 79,100 | -0.4% | 11,502,637,250 |
| 넥스턴앤롤코리아 | 2,085 | -0.5% | 85,281,710 |
| 대웅제약 | 111,100 | -0.7% | 1,374,070,900 |
| 인벤티지랩 | 24,950 | -1.4% | 1,491,692,625 |
| 고바이오랩 | 2,770 | -2.5% | 44,712,235 |
| HLB제약 | 6,450 | -2.7% | 619,635,955 |
| 펩트론 | 139,100 | -4.7% | 16,492,239,650 |
| 올릭스 | 100,100 | -8.4% | 36,170,927,400 |
This page's data is for reference only and is not investment advice. Actual market data may differ.